Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma

The expression of the HLA class I molecules on the cell surface was investigated in hepatocellular carcinoma (HCC) cell lines using complement‐mediated cytotoxicity (CMC) and flow cytometric analysis. Although HLA‐A antigens were detected by CMC in all cell lines tested, HLA‐B and ‐C antigens were not detectable in six of seven HCC cell lines. These results were also confirmed by flow cytometric analysis focusing on HLA‐Bw4 and Bw6 public antigens. Furthermore, complementary DNA (cDNA) from each cell line was tested for the expression of HLA‐A, ‐ B, ‐C and the transporter associated with antigen processing genes (TAP1 and TAP2). Two cell lines showed a reduced level of one or both of the TAP messenger RNAs (mRNAs), and one of these showed a reduction of HLA‐B and ‐C gene expression as well, but the others had detectable mRNA levels. These results demonstrate that hepatocellular carcinoma cell lines tested in the current study lose or decrease the expression of HLA‐B and ‐C alleles on the cell surface, even though mRNA encoding these alleles is present, suggesting that the loss of the HLA molecules might be caused by posttranscriptional events or failure to transport and load peptides necessary for HLA expression. The selective loss of HLA‐B and ‐C, but not ‐A, molecules (which also excludes a β2‐microglobulin defect) is intriguing, and may be attributable to the ability of some of the HLA‐A molecules to load signal peptides not requiring TAP transport, or to natural selection of HLA‐B or ‐C locus‐ specific immune surveillance.

[1]  C. Barnstable,et al.  The structure and evolution of the HLA--Bw4 and Bw6 antigens. , 2008, Tissue antigens.

[2]  M. Barnardo,et al.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.

[3]  P. Parham,et al.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.

[4]  A. Harris,et al.  Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. , 1994, The American journal of pathology.

[5]  P. Parham,et al.  NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules , 1994, The Journal of experimental medicine.

[6]  G. Trinchieri.  Recognition of major histocompatibility complex class I antigens by natural killer cells , 1994, The Journal of experimental medicine.

[7]  A. Wadee,et al.  HLA expression in hepatocellular carcinoma cell lines , 1994, Clinical and experimental immunology.

[8]  F. Marincola,et al.  Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. , 1994, Journal of immunology.

[9]  F. Marincola,et al.  Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[10]  D. Pardoll.  A new look for the 1990s , 1994, Nature.

[11]  Kenichi Tanaka,et al.  Biological‐clinical significance of selective loss of HLA‐class‐I allelic product expression in squamous‐cell carcinoma of the uterine cervix , 1994, International journal of cancer.

[12]  P. A. Peterson,et al.  Interaction of MHC class I molecules with the transporter associated with antigen processing. , 1994, Science.

[13]  P. Cresswell,et al.  MHC class l/β2-microglobulin complexes associate with TAP transporters before peptide binding , 1994, Nature.

[14]  J. Lechner,et al.  A method for transforming human liver epithelial cells by transfection using a plasmid containing SV40 early region gene , 1994 .

[15]  C. Meijer,et al.  Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas , 1994, The Journal of experimental medicine.

[16]  P. Stern,et al.  Natural history of HLA expression during tumour development. , 1993, Immunology today.

[17]  J. Bodmer,et al.  Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[18]  A. Houghton,et al.  Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA. , 1993, The Journal of clinical investigation.

[19]  S. Tonegawa,et al.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.

[20]  B. Rigas,et al.  Loss of colonic HLA antigens in familial adenomatous polyposis. , 1992, Cancer research.

[21]  R. Henderson,et al.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.

[22]  M. Loda,et al.  p53 Gene Expression in Medulloblastoma by Quantitative Polymerase Chain Reaction , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[23]  J. Strominger,et al.  Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Robert DeMars,et al.  Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter , 1991, Nature.

[25]  T. F. Rinke de Wit,et al.  The role of MHC class I expression in developmental tumours. , 1991, Seminars in cancer biology.

[26]  Smith Me.  MHC antigen expression in colorectal tumours. , 1991 .

[27]  F. Garrido,et al.  MHC expression on human tumors--its relevance for local tumor growth and metastasis. , 1991, Seminars in cancer biology.

[28]  J. Monaco,et al.  Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.

[29]  P. Parham.  Transporters of delight , 1990, Nature.

[30]  H. Ljunggren,et al.  Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.

[31]  F. Esteban,et al.  Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx , 1989, International journal of cancer.

[32]  D. B. Amos,et al.  A monoclonal antibody directed against the HLA-Bw6 epitope. , 1982, Journal of immunology.

[33]  N. Nemoto,et al.  Metabolic activation of benzo[a]pyrene, aflatoxin B1, and dimethylnitrosamine by a human hepatoma cell line. , 1982, Mutation research.

[34]  P. Parham,et al.  Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. , 1981, Human immunology.

[35]  Ivan Damjanov,et al.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.

[36]  A. Rosenthal.  Determinant Selection and Macrophage Function in Genetic Control of the Immune Response , 1978, Immunological reviews.

[37]  J. Urbanowicz,et al.  Hepatitis B surface antigen produced by a human hepatoma cell line , 1976, British Journal of Cancer.

[38]  D. Pardoll.  Tumour antigens. A new look for the 1990s. , 1994, Nature.

[39]  A. Hill,et al.  MHC loss in colorectal tumours: evidence for immunoselection? , 1992, Cancer surveys.

[40]  S. Ferrone,et al.  Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. , 1991, The Journal of clinical investigation.

[41]  M. Smith.  MHC antigen expression in colorectal tumours. , 1991, Seminars in cancer biology.

[42]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[43]  T. Fuller,et al.  Public epitopes and the antigenic structure of the HLA molecules. , 1987, Critical reviews in immunology.

[44]  R. Schwartz.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. , 1985, Annual review of immunology.

[45]  R M Zinkernagel,et al.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.